Sulfated polysaccharides extracted from brown algae are unique algal polysaccharides and potential ingredients in the cosmeceutical, functional food, and pharmaceutical industries. Therefore, the present study evaluated the cosmeceutical effects, including antioxidant, anti-wrinkle, anti-inflammation, and photoprotective activities, of Ishige okamurae Celluclast extract (IOC). The IOC was abundant in sulfated polysaccharides (48.47%), polysaccharides (44.33%), and fucose (43.50%). Moreover, the IOC effectively scavenged free radicals, and its anti-inflammatory properties were confirmed in lipopolysaccharide-induced RAW 264.7 macrophages; therefore, the IOC may produce auxiliary effects by inhibiting reactive oxygen species (ROS). In vitro (Vero cells) and in vivo (zebrafish) studies further confirmed that the IOC produced a protective effect against hydrogen-peroxide-induced oxidative stress in a dose-dependent manner. In addition, the IOC suppressed intracellular ROS and apoptosis and enhanced HO-1 and SOD-1 expression through transcriptional activation of Nrf2 and downregulation of Keap1 in HaCaT cells. Furthermore, the IOC exhibited a potent protective effect against ultraviolet-B-induced skin damage and photoaging. In conclusion, the IOC possesses antioxidant, anti-inflammatory, and photoprotective activities, and can, therefore, be utilized in the cosmeceutical and functional food industries.
A bacterial strain, designated EC11T was isolated from brown alga Ecklonia cava collected from Jeju Island, Korea. EC11T was identified as a Gram-negative, rod-shaped and yellowpigmented bacterial strain. The strain EC11T grew over a temperature range of 10°C to 30°C (optimally at 25°C), and a pH range of 6.0–10.5 (optimally at pH 7.5). Phylogenetic analysis based on 16S rRNA gene sequences showed that strain EC11T belongs to the genus Flavobacterium. Strain EC11T shared close similarity with Flavobacterium jumunjinense HME7102T (96.4%), Flavobacterium dongtanense LW30T (95.8%), Flavobacterium haoranii LQY-7T (95.3%), and Flavobacterium urocaniciphilum (95.1%). The major fatty acids (> 5%) were iso-C17:0 3-OH (22.4%), iso-C15:0 3-OH (19.0%), C15:0 (12.4%), summed feature 3 (comprising C16:1ω7c/ C16:1ω6c; 9.78%), iso-C15:1 G (9.6%), and iso-C16:0 3-OH (9.0%). The DNA G+C content was 28.1 mol% and the strain contained MK-6 as the predominant menaquinone. The major polar lipids were phosphatidylethanolamine, two unknown aminolipids and three unknown polar lipids. Based on phenotypic, chemotaxonomic and phylogenetic analysis, strain EC11T represents a novel species of the Flavobacterium genus, for which the name Flavobacterium jejuensis sp. nov. is proposed. The type strain of F. jejuensis is EC11T (=KCTC 42149T = JCM 30735T).
Airborne particulate matter (PM) originating from industrial processes is a major threat to the environment and health in East Asia. PM can cause asthma, collateral lung tissue damage, oxidative stress, allergic reactions, and inflammation. The present study was conducted to evaluate the protective effect of eckmaxol, a phlorotannin isolated from Ecklonia maxima, against PM-induced inflammation in MH-S macrophage cells. It was found that PM induced inflammation in MH-S lung macrophages, which was inhibited by eckmaxol treatment in a dose-dependent manner (21.0–84.12 µM). Eckmaxol attenuated the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in PM-induced lung macrophages. Subsequently, nitric oxide (NO), prostaglandin E-2 (PGE-2), and pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) were downregulated. PM stimulated inflammation in MH-S lung macrophages by activating Toll-like receptors (TLRs), nuclear factor-kappa B (NF-κB), and mitogen-activated protein kinase (MAPK) pathways. Eckmaxol exhibited anti-inflammatory properties by suppressing the activation of TLRs, downstream signaling of NF-κB (p50 and p65), and MAPK pathways, including c-Jun N-terminal kinase (JNK) and p38. These findings suggest that eckmaxol may offer substantial therapeutic potential in the treatment of inflammatory diseases.